Rutger J. Röring
@therealmonocyte.bsky.social
Postdoctoral researcher @ Murdoch Children's Research Institute in Melbourne | 🇳🇱➡️🇦🇺 | Childhood inflammation, cardiometabolic disease, monocytes/macrophages, trained immunity | Views are my own
Reposted by Rutger J. Röring
Fantastic talk "A high-dimensional flow cytometry profiling on peripheral blood mononuclear cells of transitioning transgender individuals" by Den Celesta from @mcri.bsky.social @unimelb.bsky.social
#YoungVIIN2025 #VIINYIS
#YoungVIIN2025 #VIINYIS
November 14, 2025 at 5:32 AM
Fantastic talk "A high-dimensional flow cytometry profiling on peripheral blood mononuclear cells of transitioning transgender individuals" by Den Celesta from @mcri.bsky.social @unimelb.bsky.social
#YoungVIIN2025 #VIINYIS
#YoungVIIN2025 #VIINYIS
Reposted by Rutger J. Röring
Ready for an inspiring day of infection and immunology presentations!! Can't wait to hear from our young investigators #YoungVIIN2025 #VIINYIS
November 13, 2025 at 9:30 PM
Ready for an inspiring day of infection and immunology presentations!! Can't wait to hear from our young investigators #YoungVIIN2025 #VIINYIS
Reposted by Rutger J. Röring
Reposted by Rutger J. Röring
New paper alert 📢! (Cell) @cp-cell.bsky.social
- How does immune responses to solid tumors vary by age and tumor characteristics in children?! www.cell.com/cell/fulltex... 🧵1/8
- How does immune responses to solid tumors vary by age and tumor characteristics in children?! www.cell.com/cell/fulltex... 🧵1/8
January 21, 2025 at 12:37 PM
New paper alert 📢! (Cell) @cp-cell.bsky.social
- How does immune responses to solid tumors vary by age and tumor characteristics in children?! www.cell.com/cell/fulltex... 🧵1/8
- How does immune responses to solid tumors vary by age and tumor characteristics in children?! www.cell.com/cell/fulltex... 🧵1/8
Reposted by Rutger J. Röring
Friends, it's fun to see the #immunology community continue to grow! I created a 4th Starter Pack to help folks find each other. If you're an immunologist and you don't see yourself on the lists, let me know 🧪
go.bsky.app/PY5tCas
go.bsky.app/FmERUoD
go.bsky.app/6aT6qDS
go.bsky.app/QSEPDoj
go.bsky.app/PY5tCas
go.bsky.app/FmERUoD
go.bsky.app/6aT6qDS
go.bsky.app/QSEPDoj
Friends, the second #immunology starter pack filled in 3 days! I started a third to help folks new to BlueSky rebuild their network
Below are the links
If you're an immunologist and I have missed you so far, let me know 🧪
go.bsky.app/PY5tCas
go.bsky.app/FmERUoD
go.bsky.app/6aT6qDS
Below are the links
If you're an immunologist and I have missed you so far, let me know 🧪
go.bsky.app/PY5tCas
go.bsky.app/FmERUoD
go.bsky.app/6aT6qDS
Wonderful to see the #immunology community growing here.
The first starter pack is full (they cap at 150), so I created a second one. Let me know if you'd like to be added
go.bsky.app/PY5tCas
go.bsky.app/FmERUoD
The first starter pack is full (they cap at 150), so I created a second one. Let me know if you'd like to be added
go.bsky.app/PY5tCas
go.bsky.app/FmERUoD
November 29, 2024 at 4:47 PM
Friends, it's fun to see the #immunology community continue to grow! I created a 4th Starter Pack to help folks find each other. If you're an immunologist and you don't see yourself on the lists, let me know 🧪
go.bsky.app/PY5tCas
go.bsky.app/FmERUoD
go.bsky.app/6aT6qDS
go.bsky.app/QSEPDoj
go.bsky.app/PY5tCas
go.bsky.app/FmERUoD
go.bsky.app/6aT6qDS
go.bsky.app/QSEPDoj
Reposted by Rutger J. Röring
This is a catastrophe. While Finland has downgraded the MDPI and Frontiers journals to level 0 (meaning these publications are not recognized for research evaluation purposes), Germany has signed an agreement to promote publications in MDPI journals.
Over 100 German Universities Partner with #MDPI in New National Agreement
Over 100 German Universities Partner with MDPI in New National Agreement
More than 100 German universities and research institutions have entered into a national agreement with MDPI. The publication agreement negotiated...
buff.ly
December 21, 2024 at 12:25 AM
This is a catastrophe. While Finland has downgraded the MDPI and Frontiers journals to level 0 (meaning these publications are not recognized for research evaluation purposes), Germany has signed an agreement to promote publications in MDPI journals.
Reposted by Rutger J. Röring
A new compelling study demonstrating that so-called “M2” macrophages, often simply classified by the surface marker CD206, are actually essential in orchestrating anti-tumor responses. This negates previous studies referring to CD206+ macs as only immunosuppressive.
rupress.org/jem/article-...
rupress.org/jem/article-...
Targeting CD206+ macrophages disrupts the establishment of a key antitumor immune axis
Specifically depleting CD206-expressing TAMs using a novel mouse model demonstrates the role of these macrophages in recruiting a tumor-reactive network of
rupress.org
November 28, 2024 at 8:11 AM
A new compelling study demonstrating that so-called “M2” macrophages, often simply classified by the surface marker CD206, are actually essential in orchestrating anti-tumor responses. This negates previous studies referring to CD206+ macs as only immunosuppressive.
rupress.org/jem/article-...
rupress.org/jem/article-...